| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c62268de3e92657ca5b9adcac4778225 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-73 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate |
2012-03-02^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_249e8c639bfd7e69d82ebef6c2e559d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c84d6677cf7ab414299a86c05ae54533
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f2158db51fe8d45362ff4fb2137af40 |
| publicationDate |
2014-03-03^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20140024863-A |
| titleOfInvention |
Aqueous solution containing hyaluronic acid or hyaluronic acid salt |
| abstract |
It relates to an aqueous solution containing highly stable hyaluronic acid or hyaluronic acid salt. An aqueous solution containing hyaluronic acid or a hyaluronic acid salt containing a divalent soluble iron of 5 ppb or less and containing a reducing agent containing iodine is provided. Another object of the present invention is to provide an aqueous solution including hyaluronic acid or hyaluronic acid salts, wherein the reducing agent is a metal iodide compound. Or, it provides the aqueous solution containing hyaluronic acid or a hyaluronic acid salt whose concentration of the said hyaluronic acid or a hyaluronic acid salt is 5-15 mg / mL. |
| priorityDate |
2011-03-02^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |